Delivery Order 36C25019D0004-36C25019N0062
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Firm Fixed Price delivery order contract to Biocompatibles, Inc., a division of Boston Scientific Corp, for the provision of INDY THERASPHERES. This is an Indefinite Delivery Indefinite Quantity (IDIQ) contract with a potential value of $407,850.00 and a completion date of September 30, 2023. The contract is for the delivery of therapeutic radiopharmaceuticals, specifically Y90 TheraSphere glass microspheres, used...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $198,000.00 firm fixed price purchase order contract to Biocompatibles, Inc., a division of Boston Scientific Corp, a manufacturer of medical devices and provider of less invasive medical solutions. The contract is for the provision of TheraSpheres yttrium-90 (Y90) therapeutic radiopharmaceutical microspheres used in interventional radiology procedures for cancer treatment. This award is not associated with a larger...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Delivery Order contract to Biocompatibles, Inc., a subsidiary of Boston Scientific Corp, to provide TheraSphere Y-90 radioactive microspheres for interventional radiology cancer treatment procedures. This Firm Fixed Price contract has a potential value of $420,000.00 and a completion date of September 30, 2023. Biocompatibles, a manufacturer of medical devices and minimally invasive medical solutions, has received...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $132,000 firm-fixed price delivery order contract to Biocompatibles, Inc., a division of Boston Scientific Corp., for the provision of Yttrium-90 TheraSphere radiopharmaceutical products. TheraSphere is a therapeutic radiopharmaceutical used in interventional radiology procedures for cancer treatment and is provided to VA hospitals and healthcare networks across the country. This award was not set aside for any...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) to Biocompatibles, Inc., a division of Boston Scientific Corp., to provide Y90 TheraSphere glass microspheres on an as-needed basis. The $3,979,000.00 firm fixed-price contract has an ultimate completion date of May 4, 2021. Biocompatibles, a manufacturer of medical devices and provider of less invasive medical solutions, has fulfilled similar contracts for these therapeutic radiopharmaceuticals used in interventional...
- The Department of Veterans Affairs Veterans Health Administration awarded a $198,000.00 firm fixed price purchase order to Biocompatibles, Inc., a division of Boston Scientific Corp, for the delivery of TheraSphere doses. Biocompatibles is a manufacturer of medical devices and provider of less invasive medical solutions, including minimally invasive radiopharmaceutical products used in cancer treatment procedures at VA hospitals and healthcare networks. This contract award is not associated with...
- This is a $16,753,208.81 definitive, firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Biocompatibles, Inc., a subsidiary of Boston Scientific Corp. The contract is for the supply of medical devices used in internal radiation and chemotherapy treatment, including Y90 TheraSphere glass microspheres and LC Bead products. The contract was awarded on February 2, 2018, with a performance period through March 31, 2023. It does not have a set-aside designation....
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $397,000.00 firm fixed price purchase order contract to Biocompatibles, Inc., a division of Boston Scientific Corp, for the supply of Y90 glass microsphere radiopharmaceuticals. This contract does not have a set-aside designation. Biocompatibles is a manufacturer of medical devices and provider of less invasive medical solutions, including therapeutic radiopharmaceuticals and surgical implants supplied to VA...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $528,000.00 Firm Fixed Price Delivery Order contract to Biocompatibles, Inc., a division of Boston Scientific Corp., for the provision of Yttrium-90 (Y90) radiopharmaceutical microspheres. This contract was awarded to support the VA's Veterans Integrated Service Network 10 and includes an option period extending through September 30, 2018. Biocompatibles is a manufacturer of medical devices and therapeutic...
- The Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract worth $273,500.00 to Biocompatibles, Inc., a division of Boston Scientific Corporation, for the supply of Yttrium-90 (Y90) TheraSphere glass microspheres used to treat liver cancer. This contract is part of the VA's Veterans Health Administration program, which provides medical solutions and technologies to VA healthcare networks across the United States. Biocompatibles, a manufacturer of medical devices...
- 36C25019D0004Indefinite Delivery Contract
- 36C25019D0004-36C25019N0062Delivery Order
The Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract to Biocompatibles, Inc., a division of Boston Scientific Corp., for the provision of INDY THERASPHERES. This is a Firm Fixed Price contract with a potential value of $297,000.00 and a completion date of September 30, 2023. The contract does not have a set-aside designation. Biocompatibles, Inc., a manufacturer of medical devices and provider of less invasive medical solutions, will deliver Y90 TheraSphere glass microspheres used in interventional radiology procedures for cancer treatment to VA hospitals and healthcare networks across the country. Boston Scientific Corp, the parent company of Biocompatibles, Inc., has previously held other prime contracts with the VA, Defense Health Agency, and National Institutes of Health for a variety of medical devices and related services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | ($577k) | 9/28/20 | |
| Not listed | Not listed | $874.5k | 10/1/18 |